Spring til hovednavigation Spring til søgning Spring til hovedindhold

Similar efficacy and tolerability of double-dose chloroquine and artemether-lumefantrine for treatment of Plasmodium falciparum infection in Guinea-Bissau: a randomized trial

  • Johan Ursing
  • , Poul-Erik Kofoed
  • , Amabelia Rodrigues
  • , Daniel Blessborn
  • , Rikke Thoft-Nielsen
  • , Anders Björkman
  • , Lars Rombo

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Abstract

In 2008, Guinea-Bissau introduced artemether-lumefantrine for treatment of uncomplicated malaria. Previously, 3 times the standard dose of chloroquine, that was probably efficacious against Plasmodium falciparum with the resistance-associated chloroquine-resistance transporter (pfcrt) 76T allele, was routinely used. The present study compared the efficacy and tolerability of a double standard dose of chloroquine with the efficacy and tolerability of artemether-lumefantrine.
OriginalsprogEngelsk
TidsskriftThe Journal of Infectious Diseases
Vol/bind203
Udgave nummer1
Sider (fra-til)109-16
Antal sider8
ISSN0022-1899
DOI
StatusUdgivet - 1. jan. 2011

Fingeraftryk

Dyk ned i forskningsemnerne om 'Similar efficacy and tolerability of double-dose chloroquine and artemether-lumefantrine for treatment of Plasmodium falciparum infection in Guinea-Bissau: a randomized trial'. Sammen danner de et unikt fingeraftryk.

Citationsformater